Abstract
Cord blood transplantation has provided an alternate stem cell source for many patients without related donors for hematopoietic stem cell transplantation. Umbilical cord blood, often discarded as a biological waste, is a potential means for cure of not only hematological disorders but also many non-hematological disorders like metabolic diseases, primary immunodeficiencies, and regenerative medicine. Though expanding donor registries for unrelated donors and the rapid adoption of haploidentical transplantation has pushed cord blood transplants to the backseat, newer technologies for expansion and manipulation of cord blood stem cells have renewed interest in this source. This chapter is a review of the evolution and current status of umbilical cord blood transplantation. Aspects covered include biology, indications, conditioning strategies, and complications of cord blood transplantation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Alkindi S, Dennison D (2011) Umbilical cord blood banking and transplantation: a short review. Sultan Qaboos Univ Med J 11(4):455–461. Epub 2011 Oct 25. PMID: 22087393; PMCID: PMC3206747
Anand S, Thomas S, Hyslop T, Adcock J, Corbet K, Gasparetto C et al (2017) Transplantation of ex vivo expanded umbilical cord blood (NiCord) decreases early infection and hospitalization. Biol Blood Marrow Transplant 23(7):1151–1157. https://doi.org/10.1016/j.bbmt.2017.04.001. Epub 2017 Apr 6. PMID: 28392378; PMCID: PMC5846194
Ballen KK, Spitzer TR, Yeap BY et al (2007) Double unrelated reduced-intensity umbilical cord blood transplantation in adults. Biol Blood Marrow Transplant 13(1):82–89
Ballen KK, Gluckman E, Broxmeyer HE (2013) Umbilical cord blood transplantation: the first 25 years and beyond. Blood 122(4):491–498. https://doi.org/10.1182/blood-2013-02-453175. Epub 2013 May 14. PMID: 23673863; PMCID: PMC3952633
Ballen KK, Verter F, Kurtzberg J (2015) Umbilical cord blood donation: public or private? Bone Marrow Transplant 50(10):1271–1278. https://doi.org/10.1038/bmt.2015.124. Epub 2015 Jun 1
Ballen KK, Logan BR, Kuxhausen M et al (2019) Use of unlicensed unrelated umbilical cord blood expands access to underserved patients: report of 2466 transplants in a racially/ethnically diverse population. Biol Blood Marrow Transplant 25(3):S221–S222
Barker JN, Weisdorf DJ, DeFor TE et al (2005) Transplantation of 2 partially HLAmatched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 105(3):1343–1347
Brunstein CG, Fuchs EJ, Carter SL et al (2011) Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts. Blood 118(2): 282–288
Cotten CM, Murtha AP, Goldberg RN et al (2014) Feasibility of autologous cord blood cells for infants with hypoxic-ischemic encephalopathy. J Pediatr 164(5):973–979.e1
Cutler C, Ballen K (2009) Reduced-intensity conditioning and umbilical cord blood transplantation in adults. Bone Marrow Transplant 44:667–671. https://doi.org/10.1038/bmt.2009.283
Cutler C, Kim HT, Sun L et al (2011) Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation. Blood 118(25):6691–6697
Dehn J, Spellman S, Hurley CK, Shaw BE, Barker JN, Burns LJ et al (2019) Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR. Blood 134(12):924–934. https://doi.org/10.1182/blood.2019001212. Epub 2019 Jul 10. PMID: 31292117; PMCID: PMC6753623
Eapen M, Rubinstein P, Zhang MJ, Stevens C, Kurtzberg J, Scaradavou A et al (2007) Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet 369(9577):1947–1954. https://doi.org/10.1016/S0140-6736(07)60915-5
Eapen M, Klein JP, Ruggeri A, Spellman S, Lee SJ, Anasetti C et al (2014) Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy. Blood 123(1):133–140. https://doi.org/10.1182/blood-2013-05-506253. Epub 2013 Oct 18. PMID: 24141369; PMCID: PMC3879902
Eapen M, Wang T, Veys PA, Boelens JJ, St Martin A, Spellman S et al (2017) Allele-level HLA matching for umbilical cord blood transplantation for non-malignant diseases in children: a retrospective analysis. Lancet Haematol 4(7):e325–e333. https://doi.org/10.1016/S2352-3026(17)30104-7. Epub 2017 Jun 13. PMID: 28623181; PMCID: PMC5699478
Feng M, Gao HX, Dai P et al (2011) Clinical observation on the efficacy of umbilical blood stem cell transplantation in 30 cases with severe cerebral palsy. Chin J Blood Transfusion 24(7):602–604
Feng M, Lu A, Gao H et al (2015) Safety of allogeneic umbilical cord blood stem cells therapy in patients with severe cerebral palsy: a retrospective study. Stem Cells Int 2015:325652
Furfaro EM, Gaballa MA (2007) Do adult stem cells ameliorate the damaged myocardium? Human cord blood as a potential source of stem cells. Curr Vasc Pharmacol 5(1):27–44
Gkazi AS, Margetts BK, Attenborough T, Mhaldien L, Standing JF, Oakes T et al (2018) Clinical T cell receptor repertoire deep sequencing and analysis: an application to monitor immune reconstitution following cord blood transplantation. Front Immunol 9:2547. https://doi.org/10.3389/fimmu.2018.02547. PMID: 30455696; PMCID: PMC6231291
Hough R, Danby R, Russell N, Marks D, Veys P, Shaw B et al (2016) Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: an update on cord blood unit selection, donor selection algorithms and conditioning protocols. Br J Haematol 172(3): 360–370. https://doi.org/10.1111/bjh.13802. Epub 2015 Nov 18
ISCTR data – Indian Stem Cell Registry Data 2012–2018
Jaing TH, Hung IJ, Yang CP, Chen SH, Chung HT, Tsay PK, Wen YC (2012) Unrelated cord blood transplantation for thalassaemia: a single-institution experience of 35 patients. Bone Marrow Transplant 47(1):33–39. https://doi.org/10.1038/bmt.2011.39. Epub 2011 Mar 7
Kurtzberg J (2017) A history of cord blood banking and transplantation. Stem Cells Transl Med 6(5): 1309–1311. https://doi.org/10.1002/sctm.17-0075. PMID: 28456005; PMCID: PMC5442723
Laughlin MJ, Barker J, Bambach B et al (2001) Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 344(24):1815–1822
Li J, McDonald CA, Fahey MC et al (2014) Could cord blood cell therapy reduce preterm brain injury? Front Neurol 5:200
Locatelli F, Kabbara N, Ruggeri A, Ghavamzadeh A, Roberts I, Li CK et al (2013) Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling. Blood 122(6):1072–1078. https://doi.org/10.1182/blood-2013-03-489112. Epub 2013 May 21
Lucchini G, Perales MA, Veys P (2015) Immune reconstitution after cord blood transplantation: peculiarities, clinical implications and management strategies. Cytotherapy 17(6):711–722. https://doi.org/10.1016/j.jcyt.2015.03.614
MacMillan ML, Weisdorf DJ, Brunstein CG, Cao Q, DeFor TE, Verneris MR, Blazar BR, Wagner JE (2009) Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors. Blood 113(11):2410–2415. https://doi.org/10.1182/blood-2008-07-163238. Epub 2008 Nov 7. PMID: 18997171; PMCID: PMC2656268
Mao F, Wu Y, Tang X et al (2017) Human umbilical cord mesenchymal stem cells alleviate inflammatory bowel disease through the regulation of 15-LOX-1 in macrophages. Biotechnol Lett 39(6):929–938
Mehta RS, Rezvani K, Olson A, Oran B, Hosing C, Shah N et al (2015) Novel techniques for ex vivo expansion of cord blood: clinical trials. Front Med (Lausanne) 2:89. https://doi.org/10.3389/fmed.2015.00089. PMID: 26697430; PMCID: PMC4675847
Meissner-Roloff M, Young W, Rangaka I, Lombaard H, Dhai A, Tsotsi N, Pepper MS (2012) Pilot social feasibility study for the establishment of a public human umbilical cord blood stem cell bank in South Africa. Stem Cell Rev Rep 8(4):1066–1075. https://doi.org/10.1007/s12015-012-9390-7
Novelo-Garza B, Limon-Flores A, Guerra-Marquez A, Luna-Bautista F, Juan-Shum L, Montero I, Sanchez-Valle E, Vélez-Ruelas MA, Mayani H (2008) Establishing a cord blood banking and transplantation program in Mexico: a single institution experience. Transfusion 48(2):228–236. https://doi.org/10.1111/j.1537-2995.2007.01529.x
Parody R, Martino R, Rovira M, Vazquez L, Vázquez MJ, de la Cámara R et al (2006) Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation. Biol Blood Marrow Transplant 12(7):734–748. https://doi.org/10.1016/j.bbmt.2006.03.007
Prasad VK, Mendizabal A, Parikh SH, Szabolcs P, Driscoll TA, Page K et al (2008) Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes. Blood 112(7):2979–2989. https://doi.org/10.1182/blood-2008-03-140830. Epub 2008 Jun 27. PMID: 18587012; PMCID: PMC2556628
Ramirez P, Nervi B, Bertin P, Poggi H, Lagos M, Selman C, Pizarro I, Jara V, Wiestruck A, Barriga F (2013) Umbilical cord blood transplantation in hematologic diseases in patients over 15 years old: long-term experience at the Pontificia Universidad Católica de Chile. Transplant Proc 45(10):3734–3739. https://doi.org/10.1016/j.transproceed.2013.08.093
Rocha V, Mohty M, Gluckman E, Rio B, Eurocord, Reduced-Intensity Conditioning Subcommittee of the Acute Leukaemia Working Party, French Society of Bone Marrow Transplantation and Cellular Therapy (2009) Reduced-intensity conditioning regimens before unrelated cord blood transplantation in adults with acute leukaemia and other haematological malignancies. Curr Opin Oncol 21(Suppl 1):S31–S34. https://doi.org/10.1097/01.cco.0000357473.58411.1b
Roura S, Pujal JM, Gálvez-Montón C, Bayes-Genis A (2015) The role and potential of umbilical cord blood in an era of new therapies: a review. Stem Cell Res Ther 6(1):123. https://doi.org/10.1186/s13287-015-0113-2. PMID: 26133757; PMCID: PMC4489204
Ruggeri A, Eapen M, Scaravadou A, Cairo MS, Bhatia M, Kurtzberg J et al (2011) Umbilical cord blood transplantation for children with thalassemia and sickle cell disease. Biol Blood Marrow Transplant 17(9): 1375–1382. https://doi.org/10.1016/j.bbmt.2011.01.012. Epub 2011 Jan 28. PMID: 21277376; PMCID: PMC3395002
Sachdeva A, Gunasekaran V, Malhotra P, Bhurani D, Yadav SP, Radhakrishnan N et al (2018) ‘Guidelines on umbilical cord blood banking’ committee of Indian Academy of Pediatrics. Umbilical cord blood banking: consensus statement of the Indian Academy of Pediatrics. Indian Pediatr 55(6):489–494
Sanz J, Montoro J, Solano C, Valcárcel D, Sampol A, Ferrá C et al (2020) Prospective randomized study comparing myeloablative unrelated umbilical cord blood transplantation versus HLA-haploidentical related stem cell transplantation for adults with hematologic malignancies. Biol Blood Marrow Transplant 26(2):358–366. https://doi.org/10.1016/j.bbmt.2019.10.014. Epub 2019 Oct 23
Scaradavou A, Brunstein CG, Eapen M et al (2013) Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia. Blood 121(5):752–758
Schoemans H, Theunissen K, Maertens J, Boogaerts M, Verfaillie C, Wagner J (2006) Adult umbilical cord blood transplantation: a comprehensive review. Bone Marrow Transplant 38(2):83–93. https://doi.org/10.1038/sj.bmt.1705403. Epub 2006 Jun 5
Sharma P, Pollyea DA, Smith CA, Purev E, Kamdar M, Haverkos B et al (2018) Thiotepa-based intensified reduced-intensity conditioning adult double-unit cord blood hematopoietic stem cell transplantation results in decreased relapse rate and improved survival compared with transplantation following standard reduced-intensity conditioning: a retrospective cohort comparison. Biol Blood Marrow Transplant 24(8):1671–1677. https://doi.org/10.1016/j.bbmt.2018.04.019. Epub 2018 Apr 21
Staba SL, Escolar ML, Poe M, Kim Y, Martin PL, Szabolcs P, Allison-Thacker J, Wood S, Wenger DA, Rubinstein P, Hopwood JJ, Krivit W, Kurtzberg J (2004) Cord-blood transplants from unrelated donors in patients with Hurler’s syndrome. N Engl J Med 350(19):1960–1969. https://doi.org/10.1056/NEJMoa032613
Stanevsky A, Goldstein G, Nagler A (2009) Umbilical cord blood transplantation: pros, cons and beyond. Blood Rev 23(5):199–204. https://doi.org/10.1016/j.blre.2009.02.001. Epub 2009 Mar 17
Sun J, Allison J, McLaughlin C et al (2010) Differences in quality between privately and publicly banked umbilical cord blood units: a pilot study of autologous cord blood infusion in children with acquired neurologic disorders. Transfusion 50(9):1980–1987
Ustun C, Giannotti F, Zhang MJ et al (2017) Outcomes of UCB transplantation are comparable in FLT3+ AML: results of CIBMTR, EUROCORD and EBMT collaborative analysis. Leukemia 31(6):1408–1414
van de Ven C, Collins D, Bradley MB et al (2007) The potential of umbilical cord blood multipotent stem cells for nonhematopoietic tissue and cell regeneration. Exp Hematol 35(12):1753–1765
Vanegas D, Triviño L, Galindo C, Franco L, Salguero G, Camacho B et al (2017) A new strategy for umbilical cord blood collection developed at the first Colombian public cord blood bank increases total nucleated cell content. Transfusion 57(9):2225–2233. https://doi.org/10.1111/trf.14190. Epub 2017 Jun 26
Wagner JE Jr, Eapen M, Carter S, Blood and Marrow Transplant Clinical Trials Network et al (2014) One-unit versus two-unit cord-blood transplantation for hematologic cancers. N Engl J Med 371(18): 1685–1694
Acknowledgments
The author wishes to place her sincere thanks to Dr. Jose Easow, Dr. Lakshmanan V, the BMT nursing team and the Infectious Disease team at the Apollo Cancer Institutes, Chennai, without whom the work on cord blood would not have been possible. Dr. Eliane Gluckman and Dr. Vinod Prasad had both been philosopher and guide during the cord program.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this entry
Cite this entry
Raj, R. (2021). Umbilical Cord Blood Transplantation. In: Chandy, M., Radhakrishnan, V.S., Sukumaran, R.K. (eds) Contemporary Bone Marrow Transplantation. Organ and Tissue Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-030-36358-1_17
Download citation
DOI: https://doi.org/10.1007/978-3-030-36358-1_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-36357-4
Online ISBN: 978-3-030-36358-1
eBook Packages: MedicineReference Module Medicine